IP Library Granted Patent US 12,391,941
Granted Patent B2
US 12,391,941 · App. 16/964,277 · Granted Aug 19, 2025

Extended single guide RNA and use thereof

Inventors: Jin-Soo Kim (Seoul, KR); Ka Yeong Lim (Seoul, KR); Beum-Chang Kang (Busan, KR); Seuk Min Ryu (Seoul, KR)
Assignee: INSTITUTE FOR BASIC SCIENCE
C12N15/11C12N9/22C12N15/907C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,391,941
App. No.
16/964,277
Granted
Aug 19, 2025
Kind
B2
Abstract

The present disclosure relates to: an extended guide RNA and a composition for base editing, comprising the same; and a method for base editing and a method for producing genetically modified animals or plants, both methods using the composition for base editing.

Claims (16)

1. A method of producing a genetically modified eukaryotic cell having a base substitution, comprising:

(a) preparing a composition for base editing comprising

(i) an adenosine base editor (ABE) or cytosine base editor (CBE),

wherein the ABE is selected from the group consisting of apolipoprotein B editing complex 1 (APOBEC1) and activation-induced deaminase (AID), the CBE is tRNA-specific adenosine deaminase (tadA);

(ii) Cas 9 nickase (nCas9); and

(iii) an extended guide RNA (ggX20) hybridizable with a target sequence,

wherein the ggX20 comprises a sequence of 20 nucleotides of the target sequence, and two additional non-complementary guanines (G) in front of 20 nucleotides in the 5′ direction from protospacer adjacent motif (PAM),

wherein the target sequence is selected from HEK2, HBB, and FANCF;

(b) introducing the composition into a eukaryotic cell,

wherein the extended guide RNA hybridizes with the target sequence,

wherein the nCas9 makes a single stranded nick,

wherein the ABE converts an adenosine to a guanine at position 18 of the target sequence in the 5′ direction from the PAM;

wherein the CBE converts a cytosine to a thymine at position 20, 21, or 23 of the target sequence in the 5′ direction from the PAM, and

wherein the base substitution does not cause a double stranded break.

2. The method according to claim 1 , wherein the composition further comprises an uracil DNA glycosylase inhibitor (UGI).

3. The method according to claim 1 , wherein the composition further comprises a nuclear localization sequence (NLS).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2020
From: KIM, JIN-SOO; LIM, KA YEONG; KANG, BEUM-CHANG; RYU, SEUK MIN
To: INSTITUTE FOR BASIC SCIENCE
Reel/Frame 053431/0111 →
Priority Claims (1)
KR 10-2018-0008492 · Jan 23, 2018 · national
Continuity (1)
Related Publication 20210032621A1 · Feb 4, 2021
References Cited (34)
US 10519454B2 · Kim · 2019 [cited by examiner]
US 11192929B2 · Harris · 2021 [cited by examiner]
US 20100076057A1 · Sontheimer et al. · 2010 [cited by applicant]
CN 101611154 · 2009 [cited by applicant]
CN 105899657 · 2016 [cited by applicant]
CN 105934516 · 2016 [cited by applicant]
CN 106834341 · 2017 [cited by applicant]
EP 3009511 · 2016 [cited by applicant]
JP 2016500003 · 2016 [cited by applicant]
JP 2017520243 · 2017 [cited by applicant]
KR 1020160133380 · 2016 [cited by applicant]
KR 1020170068400 · 2017 [cited by applicant]
WO 2015133554 · 2015 [cited by applicant]
WO 2016134081 · 2016 [cited by applicant]
WO 2017070632 · 2017 [cited by applicant]
WO 2017183724 · 2017 [cited by applicant]
Nishida K. et al., Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. Sep. 16, 2016;353(6305):aaf8729. doi: 10.1126/science.aaf8729. Epub Aug. 4, 2016 (Year: 2016). [cited by examiner]
Zhang et al., Different Effects of sgRNA Length on CRISPR-mediated Gene Knockout Efficiency, Scientific Reports, 2016, 6, 1-10. ( Jun. 24, 2016) (Year: 2016). [cited by examiner]
Zhang XH et al. Off-target Effects in CRISPR/Cas9-mediated Genome Engineering. Mol Ther Nucleic Acids. Nov. 17, 2015;4(11): e264. doi: 10.1038/mtna.2015.37. PMID: 26575098; PMCID: PMC4877446. (Year: 2015). [cited by examiner]
Bin Li et al., “Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiency”, Nat Biomed Eng. 1(5), May 10, 2017. doi:10.1038/s41551-017-0066. [cited by applicant]
F Ann Ran et al., “Genome engineering using the CRISPR-Cas9 system”, Nat Protoc, 8(11): 2281-2308. Oct. 24, 2013. doi:10.1038/nprot.2013.143. [cited by applicant]
Je Wook Woo et al., “DNANA-free genome editing in plants with preassembled CRISCRISCRISCRISPR-Cas9 ribonucleoproteins”, nature biotechnology, vol. 33, No. 11, Oct. 19, 2015. doi:10.1038/nbt.3389. [cited by applicant]
Jian-Ping Zhang et al, “Different effects of sgRNA length on CRISPR-mediated gene knockout efficiency”, Scientific Reports, vol. 6, No. 1, Jun. 1, 2016. [cited by applicant]
Yuan Zong et al., “Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion”, Nature Biotechnology, vol. 35, No. 5, pp. 438-440, Feb. 27, 2017. [cited by applicant]
EPO, Supplementary European Search Report of EP patent application No. 19743145.5, Sep. 17, 2021. [cited by applicant]
JPO, Office Action of patent application No. 2020-561562, Sep. 17, 2021. [cited by applicant]
Satomi Banno et al., “Deaminase-mediated multiplex genome editing in [cited by applicant]
Tomoko Kato-Inui et al., “Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair”, Nucleic Acids Research, vol. 46, I… [cited by applicant]
Seuk-Min Ryu et al., “Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy”, Nature Biotechnology vol. 36, pp. 536-539, Apr. 27, 2018, https://doi.org/10.1038/nbt.4148. [cited by applicant]
JPO, Office Action of JP 2020-561562 dated Apr. 7, 2022. [cited by applicant]
SIPO, Office Action & Search Report of CN 201980014548.2, dated Mar. 3, 2023. [cited by applicant]
Daesik Kim et al., “Digenome-seq: genome-wide profiling of CRIScrisPR-Cas9 off-target effects in human cells”, Nature Methods, vol. 12 No. 3, pp. 237-243, Feb. 9, 2015. [cited by applicant]
SIPO, Office Action of CN 201980014548.2 dated Dec. 27, 2023. [cited by applicant]
SIPO, Search Report of CN 201980014548.2 dated Dec. 26, 2023. [cited by applicant]